TTM
$9.05
YoY change
+13.8%
5Y CAGR
-3.6%
Peak year (2021)
$15.53
Latest annual
$8.75
EPS (Diluted) history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $8.75
EPS (Diluted) growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +13.8%
EPS (Diluted) history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $8.75 | +13.8% | +$1.06 | ||
| 2024 | $7.69 | +2.3% | +$0.17 | ||
| 2023 | $7.52 | -5.8% | −$0.46 | ||
| 2022 | $7.98 | -48.6% | −$7.55 | ||
| 2021 | $15.53 | +47.6% | +$5.01 | ||
| 2020 | $10.52 | +67.2% | +$4.23 | ||
| 2019 | $6.29 | +18.9% | +$1.00 | ||
| 2018 | $5.29 | -3.8% | −$0.21 | ||
| 2017 | $5.50 | +22.0% | +$0.99 | ||
| 2016 | $4.51 | -7.4% | −$0.36 | ||
| 2015 | $4.87 | +27.8% | +$1.06 | ||
| 2014 | $3.81 | -31.2% | −$1.73 | ||
| 2013 | $5.54 | +60.1% | +$2.08 | ||
| 2012 | $3.46 | +18.5% | +$0.54 | ||
| 2011 | $2.92 | -27.9% | −$1.13 | ||
| 2010 | $4.05 | +4.7% | +$0.18 | ||
| 2009 | $3.87 | +30.3% | +$0.90 | ||
| 2008 | $2.97 | +70.7% | +$1.23 | ||
| 2007 | $1.74 | -40.8% | −$1.20 | ||
| 2006 | $2.94 | +10.5% | +$0.28 | ||
| 2005 | $2.66 | +13.2% | +$0.31 | ||
| 2004 | $2.35 | +16.3% | +$0.33 | ||
| 2003 | $2.02 | +24.7% | +$0.40 | ||
| 2002 | $1.62 | +95.2% | +$0.79 | ||
| 2001 | $0.83 | +53.7% | +$0.29 | ||
| 2000 | $0.54 | -2260.0% | +$0.57 | ||
| 1999 | −$0.03 | -111.4% | −$0.24 | ||
| 1998 | $0.22 | -215.8% | +$0.41 | ||
| 1997 | −$0.19 | -96.4% | +$5.14 | ||
| 1996 | −$5.33 | — | — |
- 2025$8.75+13.8%
- 2024$7.69+2.3%
- 2023$7.52-5.8%
- 2022$7.98-48.6%
- 2021$15.53+47.6%
- 2020$10.52+67.2%
- 2019$6.29+18.9%
- 2018$5.29-3.8%
- 2017$5.50+22.0%
- 2016$4.51-7.4%
- 2015$4.87+27.8%
- 2014$3.81-31.2%
- 2013$5.54+60.1%
- 2012$3.46+18.5%
- 2011$2.92-27.9%
- 2010$4.05+4.7%
- 2009$3.87+30.3%
- 2008$2.97+70.7%
- 2007$1.74-40.8%
- 2006$2.94+10.5%
- 2005$2.66+13.2%
- 2004$2.35+16.3%
- 2003$2.02+24.7%
- 2002$1.62+95.2%
- 2001$0.83+53.7%
- 2000$0.54-2260.0%
- 1999−$0.03-111.4%
- 1998$0.22-215.8%
- 1997−$0.19-96.4%
- 1996−$5.33—
EPS (Diluted) values are taken from Quest Diagnostics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current diluted EPS (TTM) is $9.05. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Quest Diagnostics (DGX) reported diluted EPS of $8.75 – grew 13.8% year-over-year.
Quest Diagnostics diluted EPS has grown for 2 consecutive years, with a -3.6% compound annual growth rate over 2020–2025 (5 years).
Between 2021 and 2025, Quest Diagnostics diluted EPS plunged 43.7%, falling from $15.53 to $8.75.
The record annual diluted EPS stands at $15.53, reached in 2021; the historical low of −$5.33 was recorded in 1996.
Quest Diagnostics EPS (Diluted) by Year
Quest Diagnostics EPS (Diluted) 2025: $8.75
2025's diluted EPS for Quest Diagnostics came in at $8.75, grew 13.8% from 2024.
Quest Diagnostics EPS (Diluted) 2024: $7.69
Quest Diagnostics posted diluted EPS of $7.69 in 2024, edged up 2.3% from 2023.
Quest Diagnostics EPS (Diluted) 2023: $7.52
In 2023, Quest Diagnostics reported diluted EPS of $7.52, declined 5.8% below 2022.
Quest Diagnostics EPS (Diluted) 2022: $7.98
Quest Diagnostics diluted EPS in 2022 was $7.98, plunged 48.6% below 2021.
Quest Diagnostics EPS (Diluted) 2021: $15.53
Quest Diagnostics diluted EPS in 2021 was $15.53.
See more financial history for Quest Diagnostics (DGX). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation